Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia
Africa accounts for the majority of HIV-1 infections worldwide caused mainly by the A and C viral subtypes rather than B subtype, which prevails in the United States and Western Europe. In Brazil, B subtype is the major subtype, but F, C, and A also circulate. These non-B subtypes present polymorphisms, and some of them occur at sites that have been associated with drug resistance, including the HIV-1 protease (PR), one important drug target. Here, we report a Molecular Dynamics study of the B and non-B PR complexed with the inhibitor ritonavir to delineate the behavior of each subtype. We compare root mean squared deviation, binding free energy by linear interaction energy approach, hydrogen bonds, and intermolecular contact surface area between inhibitor and PR. From our results, we can provide a basis to understand the molecular mechanism of drug resistance in non-B subtypes. In this sense, we found a decrease of approx 4 kcal/mol in ΔG of binding between B and non-B subtypes. This corresponds to the loss of one hydrogen bond, which is in agreement with our H-bond analysis. Previous experimental affinity studies reported analogous results with inhibition constant values for non-B PR.
Index EntriesMolecular Dynamics Gromacs HIV-1 protease ritonavir subtypes non-B modelling free energy LIE
Unable to display preview. Download preview PDF.
- 7.UNAIDS (2004) AIDS epidemic update: 2004. UNAIDS/WHO, Geneva, Switzerland.Google Scholar
- 8.Osmanov, S., Pattou, C., Walker, N., Schwardlander, B., Esparza, J. and Charact, W.-U.N.H.I. (2002) Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J. Acquir. Immun. Defic. Syndr. 29, 184–190.Google Scholar
- 19.Caride, E., Hertogs, K., Larder, B., et al. (2001) Genotypic and phenotypic evidence of different drugresistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virus Genes 23, 193–202.PubMedCrossRefGoogle Scholar
- 23.van Gunsteren, W. F., Billeter, S. R., Eising, A. A., et al. (1996) Biomolecular Simulation: The GROMOS96 Manual and User Guide. vdt Hochschulverlag AG an der ETH Zürich and BIOMOS b.v., Zürich Groningen.Google Scholar
- 25.van Gunsteren, W. F. and Berendsen, H.J.C. (1987) Groningen Molecular Simulation (GROMOS) Library Manual. BIOMOS b.v., Groningen.Google Scholar
- 26.Frisch, M. J., Trucks, G. W., Schlegel, H. B., et al. (1995) GAUSSIAN94, Revision B.1 Gaussian, Inc., Pittsburgh, PA.Google Scholar
- 27.van der Spoel, D., van Buuren, A. R., Apol,, E., et al. (2001) Gromacs User’s Manual version 3.0, Groningen.Google Scholar
- 29.Humphrey, W., Dalke, A. and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38,27–38.Google Scholar
- 30.Berendsen, H. J. C., Postma, J. P. M., Gunsteren, W. F. V., and Hermans, J. (1981) Interaction models for water in relation to protein hydration, in Intermolecular Forces (Pullman, B., ed.), Reidel, Dordrecht, The Netherlands, pp. 331–342.Google Scholar
- 44.Koradi, R., Billeter, M. and Wuthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51–55, 29–32.Google Scholar
- 45.Wang, W. and Kollman, P. A. (2001) Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance. Proc. Natl. Acad. Sci. USA. 98, 14,937–14,942.Google Scholar
- 47.Garrett, R. and Grisham, C. M. (1995) Biochemistry, Saunders College Pub, Fort Worth, TX.Google Scholar